The EU-Africa PerMed project benefits from a multidisciplinary and international external Advisory Board, composed by a group of 5 members, that will contribute with their expertise and valuable knowledge to achieve the project objectives successfully.
|Dr. Ulrike Bußhof||Dr. Bußhoff obtained her PhD in biology from the University of Heidelberg. She is a senior scientific officer at the Project Management Agency at German Aerospace Centre (DLR-PT), where she is managing national and European research funding programmes for personalised medicine and global health on behalf of the German Federal Ministry of Education and Research.|
Dr. Bußhoff is part of the ICPerMed Secretariat, a Coordination and Support Action (CSA) for the International Consortium for Personalised Medicine (ICPerMed), an initiative to step up coordination efforts between funding organisations in the area of personalised medicine research.
|Prof. Moses Bockarie||Prof. Bockarie, a Fellow of the Royal College of Physicians of Edinburgh, is a specialist in the field of neglected infectious diseases and an internationally experienced researcher. He has worked in many countries in Africa, Europe and the Pacific region, and in the United States of America.|
He is the 2016 recipient of the Royal Society of Tropical Medicine and Hygiene Mackay Medal for outstanding work in tropical health. Professor Bockarie is also Chair of the WHO/TDR Scientific Working Group for Vectors, Environment and Society and a member of the WHO Regional Programme Review Group for Neglected Tropical Diseases in the African Region. He is now the Director of International Cooperation (Africa) and Head of Africa Office of European & Developing Countries Clinical Trials Partnership (EDCTP).
|Prof. Godfrey Biemba||Prof. Biemba is Director and Chief Executive Officer of the National Health Research Authority (NHRA) in Zambia. He is also Adjunct Research Assistant Professor of Global Health at Boston University School of Public Health. Before his appointment as NHRA CEO, Dr. Biemba was a Research Assistant Professor of Global Health at Boston University School of Public Health (BUSPH) from 2008 to 2017 and Country Director of the Zambian Center for Applied Health Research and Development (ZCAHRD) Limited from 2010 to 2017.|
Pro. Biemba holds a M.Sc. degree in Public Health in Developing Countries from London School of Hygiene and Tropical Medicine, London, UK, obtained in 2003. Has several post-graduate diplomas and certificates in Tropical Medicine, Research Methodologies, and Research Ethics as well as health systems management. He has over 34 years’ experience in the health sector as a medical practitioner, trainer/capacity builder, researcher, and public health manager.
|Prof. Michèle Ramsay||Prof, Ramsay is the director of the Sydney Brenner Institute for Molecular Bioscience (SBIMB) at the University of the Witwatersrand, Johannesburg (S. Africa). Professor in Human Genetics and South African Research Chair in Genomics and Bioinformatics of African Populations. Dr. Ramsay obtained her PhD in Human Molecular Genetics from the University of the Witwatersrand.|
She is a member of the Human Heredity and Health in Africa Consortium (H3Africa) where she leads the AWI-Gen study on the genetic and environmental contributions to obesity and cardiometabolic disease risk in six centres across four African countries. Her research aims to shed light on the role of African population genomic variation in susceptibility to diseases, given the ethnolinguistic and environmental diversity across the continent. The SBIMB has a research focus to support translational genomics in Africa. Michèle is the President of the International Federation of Human Genetics Societies and past President of the African Society of Human Genetics. She is the winner of the 2019 South African Women in Science Awards (SAWiSA): Distinguished Women in the Natural (Life and Physical) Sciences and Engineering category.
|Prof. Angela Brand||Prof. Brand is founding Director and Full Professor of the Institute for Public Health Genomics (IPHG) at the Faculty of Health, Medicine and Life Sciences at Maastricht University, the Netherlands, as well as Dr. T.M.Pai Endowed Chair on Public Health Genomics and Adjunct Professor at the Manipal Life Sciences Centre of Manipal University, India. Before she worked in the clinics, at various academic institutions and in governmental bodies in the USA and Germany. She is a Paediatrician and Specialist in Public Health Medicine, holds a PhD in pathology (Münster University, Germany) and a Master of Public Health from Johns Hopkins University, USA. She has been the pioneer of Public Health Genomics in Europe and established successfully this field in more than 15 European Member States within the last years. Public Health Genomics is the field within Public Health demonstrating the need for a holistic “systems thinking” and translating research from “cell to society” towards the implementation of personalised healthcare.|
Prof. Collen Masimirembwa
|Prof. Masimirembwa is the Founding President and Chief Executive Officer of the African Institute of Biomedical Science and Technology (AiBST) in Zimbabwe. He is also a Distinguished Professor at the University of the Witwatersrand working at the Sydney Brenner Institute for Molecular Bioscience (SBIMB). Collen obtained his PhD in Medical Biochemistry and Biophysics from the Karolinska Institute, Sweden.|
His research focus is in pharmacogenetics and pharmacokinetics for drug discovery and development. His work focuses on the genomic diversity of pharmacogenes in African populations and its implications for the safe and efficacious treatment of infectious and non-communicable disease in people of African ancestry. He has developed the first registered clinical pharmacogenetic testing panel in Africa, GenoPharm, that is inclusive of genetic variations unique to Africans. He has also initiated a successful MSc in Genomics and Precision Medicine program. To promote international collaboration in precision medicine, Collen is the Chair of the Developing World (South America, Africa & Middle East and South East Asia) Committee in the Pharmacogenomics Global Research Network (PGRN). His work has won several awards including the Human Genome Organisations (HUGO) Award for Africa in 2019. Collen is a fellow of the Zimbabwe Academy of Sciences (ZAS) and of the African Academy of Sciences (AAS).